Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation

Advanced Drug Delivery Reviews

Volumn 40, Issue 3, 2000, Pages 213-218

  Chang, T M S ^a   D'Agnillo, F ^a   Yu, W P ^a   Razack, S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Biodegradable polymer; Bioencapsulation; Blood substitutes; Catalase; Hemoglobin; Ischemia reperfusion; Microencapsulation; Nanoencapsulation; Nanotechnology; Polyhemoglobin; Superoxide dismutase

Indexed keywords

BIODEGRADATION; CHEMICAL MODIFICATION; CROSSLINKING; ENCAPSULATION; ENZYMES; HEMOGLOBIN; POLYMERIC MEMBRANES;

ISCHEMIA REPERFUSION; NANOENCAPSULATION; SUPEROXIDE DISMUTASE;

BLOOD SUBSTITUTES;

BLOOD SUBSTITUTE; CATALASE; HEMOGLOBIN; HEMOGLOBIN DERIVATIVE; NANOCAPSULE; SUPEROXIDE DISMUTASE;

ARTICLE; HEMORRHAGIC SHOCK; HUMAN; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; STROKE;

ANIMALS; BLOOD SUBSTITUTES; CATALASE; HEMOGLOBINS; HUMANS; MICROSPHERES; POLYMERS; REPERFUSION INJURY; SUPEROXIDE DISMUTASE;

EID: 0342980853     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(99)00051-4     Document Type: Article

References (31)

1. Chang T.M.S. Semipermeable microcapsules. Science. 146:(3643):1964;524.
2. Chang T.M.S. Artificial Cells. Monograph :1972;Charles C. Thomas, Springfield, IL.
3. Chang T.M.S. Stabilization of enzyme by microencapsulation with a concentrated protein solution or by crosslinking with glutaraldehyde. Biochem. Biophys. Res. Com. 44:1971;1531-1533.
4. Hsia J.C. o-Raffinose polymerized hemoglobin as red blood cell substitute. Biomaterial Art. Cells Immob. Biotechnol. 19:1991;402.
5. Gould S.A., Sehgal L.R., Sehgal H.L., DeWoskin R., Moss G.S. The clinical development of human polymerized hemoglobin. Chang T.M.S. Blood Substitutes: Principles, Methods, Products and Clinical Trials. 1998;12-28 Karger, Basel.
6. Pearce L.B., Gawryl M.S. Overview of preclinical and clinical efficacy of Biopure's HBOCs. Chang T.M.S. Blood Substitutes: Principles, Methods, Products and Clinical Trials. 1998;82-98 Karger, Basel.
7. Adamson J.G., Moore J.G.C. Hemolink TM, an o-Raffinose crosslinked hemoglobin-based oxygen carrier. Chang T.M.S. Blood Substitutes: Principles, Methods, Products and Clinical Trials. 1998;62-79 Karger, Basel.
8. Chang T.M.S. Artificial Blood: a prospective. Trends Biotechnol. 17:1999;61-67.
9. Rudolph A.S., Rabinovici R., Feuerstein G.Z. Red Blood Cell Substitutes. 1997;Marcel Dekker, New York, NY.
10. Tsuchida E. Blood Substitutes. 1998;Elsevier, Amsterdam.
11. Winslow R.M. Blood Substitutes in Development. 1996;Ashley Publications, London.
12. Chang T.M.S. Blood Substitutes: Principles, Methods, Products and Clinical Trials. 1997;Karger, Basel.
13. Chang T.M.S. Modified hemoglobin-based blood substitutes: crosslinked, recombinant and encapsulated hemoglobin. Vox Sanguinis. 74:(2):1998;233-241.
14. Alayash A.I., Brockner-Ryan B.A., McLeod L.L., Goldman D.W., Cashon R.E. Cell-free hemoglobin and tissue oxidants: probing the mechanisms of hemoglobin cytotoxicity. Chang T.M.S. Blood Substitutes: Principles, Methods, Products and Clinical Trials. 1998;157-174 Basel Karger, Texas Landes.
15. D'Agnillo F., Chang T.M.S. Cross-linked hemoglobin-superoxide dismutase-catalase scavenges oxygen-derived free radicals and prevents methemoglobin formationand iron release. Biomaterials, Artificial Cells and Immobilization Biotechnology. 21:1993;609-622.
16. Quebec E.A., Chang T.M.S. Superoxide dismutase and catalase crosslinked to polyhemoglobin reduces methemoglobin formation in-vitro. J. Art. Cells Blood Substitutes Immob. Biotechnol. 25:1995;693-706.
17. D'Agnillo F F., Chang T.M.S. Modified hemoglobin blood substitute from Cross-linked hemoglobin-superoxide dismutase-catalase. US patent 5,606,025, Feb, 1997 :1997.
18. D'Agnillo F., Chang T.M.S. Production of hydroxyl radical generation in a rat hindlimb model of ischemia-reperfusion injury using crosslinked hemoglobin superoxide dismutase-catalase. J. Art. Cells Blood Substitutes Immob. Biotechnol. 25:1997;163-180.
19. Razack S., D'Agnillo F., Chang T.M.S. Crosslinked hemoglobin superoxide dismutase-catalase scavenges free radicals in a rat model of intestinal ischemia-reperfusion injury. J. Art. Cells Blood Substitutes Immob. Biotechnol. 25:1997;181-192.
20. Chang T.M.S., D'Agnillo F., Razack S. Crosslinked hemoglobin superoxide dismutase-catalase: a second generation hemoglobin based blood substitute with antioxidant activities, in. Chang T.M.S. Blood Substitutes: Principles, Methods, Products and Clinical Trials. 1997;178-196 Karger, Basel, Switzerland.
21. D'Agnillo F., Chang T.M.S. Absence of hemoprotein-associated free radical events following oxidant challenge of crosslinked hemoglobin-superoxide dismutase-catalase. Free Radical Biology & Medicine. 24:(6):1998;906-912.
22. D'Agnillo F., Chang T.M.S. Polyhemoglobin-superoxide dismutase catalase as a blood substitute with antioxidant properties. Nature Biotechnol. 167:1998;667-671.
23. T.M.S. Chang, Hemoglobin corpuscles. Report of a research project of B.Sc. Honours Physiology, McGill University, 1-25, 1957. Medical Library, McIntyre Building, McGill University,1957 (reprinted in Biomaterials, Artificial Cells and Artificial Organs 16:1-9, 1988).
24. Chang T.M.S., Poznansky M.J. Semipermeable microcapsules containing catalase for enzyme replacement in acatalsaemic mice. Nature. 218:(5138):1968;242-245.
25. T.M.S. Chang, Ph.D. Thesis, McGill University, 1965.
26. Djordjevich L., Miller I.F. Synthetic erythrocytes from lipid encapsulated hemoglobin. Exp. Hematol. 8:1980;584.
27. Chang T.M.S. Biodegradable semipermeable microcapsules containing enzymes, hormones,vaccines, and other biologicals. J. Bioengrg. 1:1976;25-32.
28. Yu W.P., Chang T.M.S. Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: A preliminary report. J. Art. Cells Blood Substitutes Immob. Biotechnol. 22:1994;889-894.
29. Yu W.P., Chang T.M.S. Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization. Art. Cells Blood Substitutes Immob. Biotechnol. 24:1996;169-184.
30. Chang T.M.S., Yu W.P. Biodegradable polymer membrane containing hemoglobin for blood substitutes. U.S.A. Patent 5670173 September, 23, 1997. 1997.
31. Chang T.M.S., Yu W.P. Nanoencapsulation of hemoglobin and red blood cell enzymes based on nanotechnology and biodegradable polymer. Blood Substitutes: Principles, Methods, Products and Clinical Trials. 1998;216-231 Karger, Basel.